---
layout: post
title: "Risk Management Plans To Mitigate the Potential for Drug Shortages; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Extension of Comment Period"
date: 2026-02-05 18:59:48 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-14809
original_published: 2022-07-12 00:00:00 +0000
significance: 8.00
---

# Risk Management Plans To Mitigate the Potential for Drug Shortages; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Extension of Comment Period

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** July 12, 2022 00:00 UTC
**Document Number:** 2022-14809

## Summary

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability entitled "Risk Management Plans to Mitigate the Potential for Drug Shortages; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request" that appeared in the Federal Register on May 20, 2022. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/07/12/2022-14809/risk-management-plans-to-mitigate-the-potential-for-drug-shortages-draft-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2022-14809

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
